4D Molecular Therapeutics Inc (FDMT)
R&D Expense Growth
5.08%
Quarterly · Period ending:
FDMT R&D Expense Growth
Latest reported5.08%period ending
Latest reported5.08%period ending
FDMT Quarterly R&D Growth (QoQ) (0.00% → 5.08%)
Latest values, visible window
High-resolution chart · PNG
FDMT r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 5.0816% | |
| 12.7968% | |
| 16.5257% | |
| 3.1011% | |
| 17.8186% | |
| -5.5379% | |
| 11.9556% | |
| 20.791% | |
| 14.3165% | |
| 7.077% | |
| 3.8379% | |
| 6.2839% | |
| 5.2293% | |
| 4.2419% | |
| 13.5164% | |
| -7.2569% | |
| 5.3712% | |
| 10.5717% | |
| 10.6566% | |
| 4.0531% | |
| 19.2184% | |
| 1.3011% | |
| 9.087% | |
| -26.4949% | |
| 19.471% | |
| 6.4649% | |
| 31.8434% | |
| 10.3797% | |
| 0% | |
| 67.274% | |
| 0% | |
| 23.7086% | |
| 0% | |
| 0% |